Impact of Lung Microbiota on COPD

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Jun 24

PMID 35740358

Authors

Cristina Russo

Valeria Colaianni

Giuseppe Ielo

Maria Stella Valle

Lucia Spicuzza

Lucia Malaguarnera

Affiliations

Soon will be listed here.

Abstract

There is a fine balance in maintaining healthy microbiota composition, and its alterations due to genetic, lifestyle, and environmental factors can lead to the onset of respiratory dysfunctions such as chronic obstructive pulmonary disease (COPD). The relationship between lung microbiota and COPD is currently under study. Little is known about the role of the microbiota in patients with stable or exacerbated COPD. Inflammation in COPD disorders appears to be characterised by dysbiosis, reduced lung activity, and an imbalance between the innate and adaptive immune systems. Lung microbiota intervention could ameliorate these disorders. The microbiota's anti-inflammatory action could be decisive in the onset of pathologies. In this review, we highlight the feedback loop between microbiota dysfunction, immune response, inflammation, and lung damage in relation to COPD status in order to encourage the development of innovative therapeutic goals for the prevention and management of this disease.

Citing Articles

Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement.

Lewicki S, Balan B, Stelmasiak M, Radomska-Lesniewska D, Szymanski L, Rios-Turek N Vaccines (Basel). 2025; 13(2).

PMID: 40006655 PMC: 11861055. DOI: 10.3390/vaccines13020107.

Exploring the potential role of microbiota and metabolites in acute exacerbation of chronic obstructive pulmonary disease.

Shi Y, Yang J, Tian T, Li S, Xie Y Front Microbiol. 2024; 15:1487393.

PMID: 39483760 PMC: 11526122. DOI: 10.3389/fmicb.2024.1487393.

The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease.

Song X, Dou X, Chang J, Zeng X, Xu Q, Xu C Gut Microbes. 2024; 16(1):2414805.

PMID: 39446051 PMC: 11509012. DOI: 10.1080/19490976.2024.2414805.

Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative review.

Guardamagna M, Meyer M, Berciano-Guerrero M, Mesas-Ruiz A, Cobo-Dols M, Perez-Ruiz E Transl Lung Cancer Res. 2024; 13(8):2050-2066.

PMID: 39263011 PMC: 11384476. DOI: 10.21037/tlcr-24-216.

The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.

Kita K, Gawinowska M, Chelminska M, Niedoszytko M Int J Mol Sci. 2024; 25(13).

PMID: 39000502 PMC: 11242091. DOI: 10.3390/ijms25137395.

References

Belkaid Y, Hand T . Role of the microbiota in immunity and inflammation. Cell. 2014; 157(1):121-41. PMC: 4056765. DOI: 10.1016/j.cell.2014.03.011. View

Young J, Chehoud C, Bittinger K, Bailey A, Diamond J, Cantu E . Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients. Am J Transplant. 2014; 15(1):200-9. PMC: 4276431. DOI: 10.1111/ajt.13031. View

Shetty S, Marathe N, Lanjekar V, Ranade D, Shouche Y . Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut. PLoS One. 2013; 8(11):e79353. PMC: 3832451. DOI: 10.1371/journal.pone.0079353. View

Yang R, Zhang Q, Ren Z, Li H, Ma Q . Different Airway Inflammatory Phenotypes Correlate with Specific Fungal and Bacterial Microbiota in Asthma and Chronic Obstructive Pulmonary Disease. J Immunol Res. 2022; 2022:2177884. PMC: 8933093. DOI: 10.1155/2022/2177884. View

Aguirre E, Galiana A, Mira A, Guardiola R, Sanchez-Guillen L, Garcia-Pachon E . Analysis of microbiota in stable patients with chronic obstructive pulmonary disease. APMIS. 2015; 123(5):427-32. DOI: 10.1111/apm.12363. View

Brooks J, Edwards D, Harwich Jr M, Rivera M, Fettweis J, Serrano M . The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 2015; 15:66. PMC: 4433096. DOI: 10.1186/s12866-015-0351-6. View

Beck J, Young V, Huffnagle G . The microbiome of the lung. Transl Res. 2012; 160(4):258-66. PMC: 3440512. DOI: 10.1016/j.trsl.2012.02.005. View

Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E . Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J Infect Dis. 2014; 210(3):493-503. DOI: 10.1093/infdis/jiu106. View

Mahooti M, Abdolalipour E, Salehzadeh A, Mohebbi S, Gorji A, Ghaemi A . Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice. World J Microbiol Biotechnol. 2019; 35(6):91. DOI: 10.1007/s11274-019-2667-0. View

10.

Engler K, Muhlemann K, Garzoni C, Pfahler H, Geiser T, von Garnier C . Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss Med Wkly. 2012; 142:w13509. DOI: 10.4414/smw.2012.13509. View

11.

Al Bander Z, Nitert M, Mousa A, Naderpoor N . The Gut Microbiota and Inflammation: An Overview. Int J Environ Res Public Health. 2020; 17(20). PMC: 7589951. DOI: 10.3390/ijerph17207618. View

12.

Kulkarni R, Antala S, Wang A, Amaral F, Rampersaud R, LaRussa S . Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. Infect Immun. 2012; 80(11):3804-11. PMC: 3486061. DOI: 10.1128/IAI.00689-12. View

13.

Fischer K, Doehn J, Herr C, Lachner C, Heinrich A, Kershaw O . Acute Airway Infection of Chronically Smoke-Exposed Mice Increases Mechanisms of Emphysema Development: A Pilot Study. Eur J Microbiol Immunol (Bp). 2019; 8(4):128-134. PMC: 6348706. DOI: 10.1556/1886.2018.00019. View

14.

Gokulan K, Joshi M, Khare S, Bartter T . Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2021; 28(2):134-138. DOI: 10.1097/MCP.0000000000000853. View

15.

Haldar K, George L, Wang Z, Mistry V, Ramsheh M, Free R . The sputum microbiome is distinct between COPD and health, independent of smoking history. Respir Res. 2020; 21(1):183. PMC: 7362436. DOI: 10.1186/s12931-020-01448-3. View

16.

Caverly L, Huang Y, Sze M . Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease. Chest. 2019; 156(2):376-382. PMC: 6945648. DOI: 10.1016/j.chest.2019.05.011. View

17.

Opron K, Begley L, Erb-Downward J, Freeman C, Madapoosi S, Alexis N . Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ Biofilms Microbiomes. 2021; 7(1):14. PMC: 7865064. DOI: 10.1038/s41522-021-00185-9. View

18.

Eapen M, Hansbro P, McAlinden K, Kim R, Ward C, Hackett T . Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Sci Rep. 2017; 7(1):13392. PMC: 5645352. DOI: 10.1038/s41598-017-13888-x. View

19.

Waqas S, Dunne K, Talento A, Wilson G, Martin-Loeches I, Keane J . Prospective observational study of respiratory Aspergillus colonization or disease in patients with various stages of chronic obstructive pulmonary disease utilizing culture versus nonculture techniques. Med Mycol. 2020; . DOI: 10.1093/mmy/myaa077. View

20.

Ramirez-Labrada A, Isla D, Artal A, Arias M, Rezusta A, Pardo J . The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy. Trends Cancer. 2020; 6(2):86-97. DOI: 10.1016/j.trecan.2019.12.007. View